MRK’s disingenuous re-definition of null responder The FDA specifically agrees with you on this in its just-released guidance: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM225333.pdf This should be good for VRTX. Peter